Name: KMTS Income Statement - Kestra Medical Technologies Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

KMTS - Kestra Medical Technologies, Ltd.

USD | NASDAQ | Healthcare

KMTS Income Statement - Kestra Medical Technologies Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q3 FY 26	Q2 FY 26	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25
Revenues
Revenues	24.6	22.6	19.4	17.2	15.1	14.7	12.8
Cost of Revenue	11.6	11.1	10.5	9.6	8.5	8.9	8.6
Gross Profit	12.9	11.4	8.9	7.6	6.5	5.8	4.2
Operating Expenses
Research & Development	5.0	4.9	4.0	5.4	3.4	3.5	3.4
Selling General & Administrative	42.7	38.3	33.7	50.5	23.8
Operating Income
Operating Income	(34.8)	(31.8)	(28.9)	(48.2)	(20.6)	(19.1)	(18.4)
Non-Operating
Interest Income	2.2	1.8	2.2	1.7	0.6	0.9	0.0
Interest Expense	1.9	1.9	1.9	1.8	1.8	2.3	1.9
Tax & Net
Income Tax Expense	0.0	0.0	0.0	0.1	0.0	0.0	0.0
Net Income From Continuing Ops	(34.2)	(32.8)	(25.8)	(51.1)	(21.8)	(20.6)
Per Share
EPS Basic	(0.61)	(0.64)	(0.50)	-	(1.25)	(1.19)	(1.12)
EPS Diluted	(0.61)	(0.64)	(0.50)	-	(1.25)	(1.19)	(1.12)
Supplementary Data
EBITDA	(32.8)	(29.4)	(26.9)	(46.4)	(18.7)	(17.3)	(16.1)
EBIT	(34.8)	(31.8)	(28.9)	(48.2)	(20.6)	(19.1)	(18.4)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024
Revenues
Revenues	83.7	59.8	27.8
Cost of Revenue	42.9	35.6	27.5
Gross Profit	40.8	24.2	0.4
Operating Expenses
Research & Development	19.2	15.7	15.5
Selling General & Administrative	165.2	114.9	69.9
Selling & Marketing	-	-	-
General & Administrative
Operating Income
Operating Income	(143.6)	(106.4)	(85.1)
Non-Operating
Interest Income	7.8	3.2	-
Interest Expense	7.5	7.7	6.2
Income From Equity Investments	-	-	-
Other Non-Operating Income
Tax & Net
Income Tax Expense	0.2	0.1	0.0
Net Income From Continuing Ops	(143.9)	(113.8)	(94.1)
Net Income From Discontinued Ops	-	-	-
Net Income
Per Share
EPS Basic	(2.65)	(5.13)	(5.07)
EPS Diluted	(2.65)	(5.13)	(5.07)
Shares Basic	55.8	24.6	19.9
Shares Diluted	55.8
Supplementary Data
EBITDA	(135.4)	(98.4)	(73.5)
EBIT	(143.6)	(106.4)	(85.1)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)